A University of Bristol-led international project investigating a new method of controlling the growth of organic crystals has been awarded €2.9m in Horizon 2020 funding (University of Bristol, 2016). The MagnaPharm project aims to direct polymorphism in pharmaceutical compounds by crystallising them in high magnetic fields. The ability to direct polymorphism would have a transformative … Continue reading Organic crystal research secures EU funding